Conmed (CNMD) Return on Capital Employed (2011 - 2026)
Conmed (CNMD) posted Return on Capital Employed of 5.53% for Q1 2026, up 8.22% on a QoQ basis from 5.11% in Q4 2025, and down 345.0% year-over-year from 2.26% in Q1 2025.
Conmed (CNMD) Return on Capital Employed (2011 - 2026) Analysis & Trends
Conmed's Return on Capital Employed history runs 16 years deep, the most recent figure standing at 5.53% for Q1 2026.
- Quarterly Return on Capital Employed fell 345.0% year-over-year to 5.53% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 5.53% (down 345.0% YoY) and the FY2025 annual result came in at 5.13%, down 476.0% from the prior year.
- Return on Capital Employed was 5.53% for Q1 2026 at Conmed, up from 5.11% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 9.85% in Q4 2024 and bottomed at 3.03% in Q1 2023.
- A 5-year average of 6.3% and a median of 6.02% in 2023 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2024 — Return on Capital Employed soared 625 bps — and 2025, when it tumbled 475 bps.
- Conmed's Return on Capital Employed stood at 3.51% in 2022, then jumped by 72 bps to 6.02% in 2023, then soared by 64 bps to 9.85% in 2024, then sank by 48 bps to 5.11% in 2025, then increased by 8 bps to 5.53% in 2026.
- Business Quant data shows CNMD's Return on Capital Employed at 5.53% in Q1 2026, 5.11% in Q4 2025, and 5.89% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 11.13% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 24.24% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.38% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 9.30% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Conmed | 1.29 Bn | 1.26 Bn | 183.45 Mn | 5.53% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.53% |
| Dec 31, 2025 | 5.11% |
| Sep 30, 2025 | 5.89% |
| Jun 30, 2025 | 8.54% |
| Mar 31, 2025 | 8.98% |
| Dec 31, 2024 | 9.85% |
| Sep 30, 2024 | 9.81% |
| Jun 30, 2024 | 8.01% |
| Mar 31, 2024 | 7.10% |
| Dec 31, 2023 | 6.02% |
| Sep 30, 2023 | 3.56% |
| Jun 30, 2023 | 3.21% |
| Mar 31, 2023 | 3.03% |
| Dec 31, 2022 | 3.51% |
| Sep 30, 2022 | 5.49% |
| Jun 30, 2022 | 6.41% |
| Mar 31, 2022 | 7.06% |
| Dec 31, 2021 | 7.02% |
| Sep 30, 2021 | 6.17% |
| Jun 30, 2021 | 6.42% |